Retour
Fourchette du Jour
6,24 €
7,32 €
Fourchette 52 Semaines
2,83 €
11,50 €
Volume
3 453 552
Moyenne 50J / 200J
8,62 €
/
7,49 €
Clôture Précédente
7,32 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (633 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,9 | 0,2 |
| P/B | 2,2 | 2,8 |
| ROE % | -35,0 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
11,25 €
+77.4%
Low: 10,00 €
High: 13,00 €
BPA Prévisionnel
-1,08 €
CA Est.
78,84M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,02 €
-0,02 € – -0,02 €
|
222,90M | 1 |
| FY2029 |
-0,13 €
-0,14 € – -0,12 €
|
180,90M | 1 |
| FY2028 |
-0,53 €
-0,55 € – -0,51 €
|
158,68M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -0,29 € | -0,26 € | +9,8% |
| 2025-11-04 | -0,28 € | -0,24 € | +14,3% |
| 2025-08-05 | -0,25 € | -0,23 € | +8,0% |
| 2025-05-06 | -0,23 € | -0,18 € | +21,7% |
| 2025-02-27 | -0,32 € | -0,23 € | +28,1% |
| 2024-11-06 | -0,33 € | -0,64 € | -93,9% |
| 2024-08-07 | -0,34 € | -0,24 € | +29,4% |
| 2024-05-08 | -0,44 € | -0,26 € | +40,9% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -79,45M
PEG of 0,26 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-35,02%
ROIC-22,54%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,12
Current Ratio6,76
Interest Coverage-429,55
Valorisation
P/E Ratio
-6,93
Forward P/EN/A
P/B Ratio2,16
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -81,27M |
| ROE | -35,02% | ROA | -24,32% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -79,45M |
| ROIC | -22,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,76 |
| Interest Coverage | -429,55 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,93 | Forward P/E | N/A |
| P/B Ratio | 2,16 | P/S Ratio | N/A |
| PEG Ratio | 0,26 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 7,14 | Fwd Earnings Yield | N/A |
| FCF Yield | -14,11% | ||
| Market Cap | 563,02M | Enterprise Value | 470,64M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 84,61M | 73,48M | 65,05M | 85,49M |
| Net Income | -81,27M | -81,28M | -108,30M | -113,32M | -65,23M |
| EPS (Diluted) | -0,91 | -1,37 | -2,25 | -2,48 | -1,49 |
| Gross Profit | -53,87M | 26,83M | 18,21M | 13,35M | 31,66M |
| Operating Income | -88,06M | -68,27M | -109,94M | -115,53M | -65,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 334,16M | 270,27M | 225,10M | 292,70M | 396,53M |
| Total Liabilities | 72,98M | 67,31M | 95,66M | 74,56M | 86,23M |
| Shareholders' Equity | 261,19M | 202,96M | 129,44M | 218,14M | 310,30M |
| Total Debt | 31,87M | 44,25M | 47,73M | 48,65M | 58,33M |
| Cash & Equivalents | 124,25M | 91,42M | 56,98M | 89,13M | 105,59M |
| Current Assets | 267,95M | 203,02M | 146,74M | 199,70M | 318,23M |
| Current Liabilities | 39,63M | 31,13M | 47,23M | 33,13M | 31,31M |